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We report here two unrelated families in Japan and Kor-
ea having patients with a unique type of epidermolysis
bullosa simplex and a novel mutation in the keratin
gene KRT5, i.e., a frameshift and delayed stop codon
inconsistent with any subtype described before. The pa-
tients showed migratory circinate erythema and multi-
ple vesicles on the circular belt-like areas a¡ected by
erythema. Electron microscopy of skin biopsies showed
a reduction in the number of keratin intermediate ¢la-
ments in the basal cells without tono¢lament clumping.
We identi¢ed a novel heterozygous deletion mutation
(1649delG of KRT5) in both cases. This deletion is pre-
dicted to produce a mutant keratin 5 protein with a fra-
meshift of its terminal 41 amino acids and 35 amino
acids longer than the wild-type keratin 5 protein due
to a delayed termination codon. As the same abnormal
elongated mutant KRT5 gene was found in the inde-
pendent families, the predicted abnormal elongated
keratin protein is likely to lead to an atypical clinical
phenotype that has never been reported, possibly by
interfering with the functional interaction between kera-
tin and its associated proteins. Key words: Dowling^Meara/
pigmentation/tail domain/V2 domain. J Invest Dermatol
121:482 ^485, 2003
E
pidermolysis bullosa simplex (EBS) is an autosomal-
dominant inherited blistering skin disease, com-
monly known as a keratin disease, caused in most
cases by point mutations in KRT14 or KRT5 genes,
and categorized into three main subtypes, i.e., EBS
Dowling^Meara (EBS-DM, OMIM 131760), EBS Kˇbner (EBS-
K, OMIM 131900), EBS Weber^Cockayne (EBS-WC, OMIM
131800) (Fine et al, 2000). Among these three primary EBS sub-
types, EBS-DM is the most severe, with clustered blisters appear-
ing at any body site following mild trauma; EBS-K is associated
with generalized blistering, whereas the mildest subtype, EBS-
WC, shows blistering restricted to the hands and feet (Horn and
Tidman, 2000).
For all EBS types, the site and type of amino acid substitution
within the keratin protein generally correlates with phenotypic
severity in this disorder (Letai et al, 1993). Every keratin protein
has a central a-helix rod domain consisting of approximately 310
amino acids residues, which is believed to be organized into
coiled-coil dimers through the hydrophobic associations of a hep-
tad repeat unit. The mechanism by which dimers associate to
form mature 10 nm intermediate ¢laments is unknown (Steinert
and Roop, 1988). This rod domain exists in four segments (i.e.,
1A, 1B, 2A, and 2B) interrupted by three nonhelix linkers,
termed the L1, L12, and L2 regions. The rod domain is £anked
on each end with nonhelical head (amino-terminal) domains,
i.e.,V1 and H1, and tail (carboxyl-terminal) domains, i.e.,V2 and
H2, although type II keratin does not have H2. The function of
these domains remains unclear, although they are likely to re£ect
in part the tissue speci¢city of keratins. These nonhelix domains
are highly variable in size and sequence even for members within
the same intermediate ¢lament subtype. In addition, two very
highly conserved regions at the beginning of the 1A region and
the end of the 2B region are termed the helix initiation motif
(HIM) and the helix termination motif (HTM), respectively
(Irvine and McLean, 1999).
The mutations ascribed to the subtype EBS-DM have primar-
ily involved changes in the highly conserved regions (i.e., HIM
and HTM). Mutations associated with EBS-WC primarily are re-
stricted to the nonhelix regions of the keratin polypeptide, in
particular the H1 domain and L12 linker region. Interestingly,
KRT5 and KRT14 mutations have been reported less frequently
in EBS-K than in the other main EBS subtypes. The mutations
of KRT5 and KRT14 in EBS-K are mainly located to the nonpo-
lar residues of the HIM and HTM regions of the rod domains.
Previous studies also have suggested that the keratin rod domains
play important roles in intermediate ¢lament assembly and orga-
nization (Steinert et al, 1993), whereas the functions of the head
and tail domains are less clear. The head region of the keratin 5
(K5) protein, however, appears to be required for both ¢lament
elongation and lateral alignments (Wilson et al, 1992). In addition,
an 18 amino acid residue stretch in the K5 head that is conserved
only among type II epidermal keratins has been demonstrated to
be critical for the binding to desmoplakin (Kouklis et al, 1994).
Indeed, mutations in the V1 domain of K5 cause relatively
mild clinical phenotypes, i.e., EBS with mottled pigmentation
(OMIM 131960) (Uttam et al, 1996). Several mutations in the ker-
atin V1 domain other than K5 have also been reported recently
(Kimonis et al, 1994; Terrinori et al, 2000). Conversely, mutations
in the V2 domain have been reported only in K1 (Sprecher et al,
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2001;Whittock et al, 2002). In this study, we noted a heterozygous
deletion mutation in the K5 V2 domain that caused a less severe
phenotype that resembled EBS-DM.
MATERIALS AND METHODS
Patients’ characteristics
Case 1 A Japanese girl, currently aged 2 y, presented to Gifu University
Hospital with symptoms of annular migratory multiple erythema circina-
tum and multiple vesicles on the hands, feet, and legs from birth. The skin
blisters continued to appear mainly on the hands, feet, and occasionally the
trunk (Fig 1a, b). The lesions were exacerbated in summer. The nails, ocu-
lar epithelia, and mucosae were not a¡ected, and laryngeal involvement
was not seen.The lesions healed without scarring but with brown pigmen-
tation, and their severity lessened with age. No other family members are
a¡ected by the same disorder.
Case 2 A Korean girl, currently aged 1 y, presented to Yongdong Sever-
ance Hospital with symptoms of erythematous annularly spreading vesicles
on the trunk and extremities since birth. The patient was born at term and
there was no abnormality at birth. The blisters resolved without scars or
milia as the new blisters annularly spread, but brown pigmentation ap-
peared in the central clearing lesions (Fig 2b). Again, the nails, ocular
epithelia, and mucosae were not a¡ected, and laryngeal involvement was
not present. The mother had a history of similar blisters in her youth, re-
ported that spontaneous improvement coincided with puberty, and now
only occasionally develops vesicles. On examination, the mother had gen-
eralized hypopigmented and hyperpigmented patches on the trunk and ex-
tremities (Fig 2c), but occasionally only small vesicles were observed in
these same areas. Pruritus reportedly develops only when new blisters ap-
pear, and the lesions tend to worsen in summer time. There was no hyper-
keratosis of the palms and soles, and no nail dystrophy. Seven individuals
of the family for three generations had a history of blistering (Fig 2a), and
all a¡ected adult members in the family had similar pigmentary changes as
the mother’s skin lesion. At the beginning of this study, informed consent
was obtained with a protocol approved by each University Review Board.
Immunohistochemistry The immuno£uorescence method (Dako,
Carpinteria, CA) was carried out on fresh tissue by using monoclonal
antibody C-50 against K5/8 (Laboratory Vision, Fremont, CA); each
section was incubated for 1 h at room temperature in a 1:40 dilution with
phosphate-bu¡ered saline. The avidin^biotin immunoperoxidase method
(Dako) was performed on formalin-¢xed, para⁄n-embedded tissue by
using monoclonal antibody RCK102 against K5/8 (Sanbio, Uden, The
Netherlands); each section was incubated for 1 h at room temperature in
1:10 dilution with phosphate-bu¡ered saline. AECþ substrate chromogen
was used as the color reagent for para⁄n-embedded specimens.
Immunostaining for K14 was also performed on fresh tissue by using
monoclonal antibody LL002 (Laboratory Vision). Normal skin was used
simultaneously as a control.
PCR ampli¢cation and DNA sequence Genomic DNAwas isolated
from ethylenediamine tetraacetic acid treated blood samples using DNA
extractorWB-rapid kit (WAKO, Osaka, Japan) and kept at ^201C prior to
use. PCR ampli¢cations of all exons of KRT5 and KRT14 were carried out
using primer pairs as described previously (Sorensen et al, 1999) and based
on information obtained from the published sequence of the KRT5 gene
(GeneBank Accession no. M21389) and KRT14 gene (GeneBank Accession
no. J00124). The cycle sequence reaction was performed using Thermo
Sequenase cycle sequencing kit (USB, Cleveland, OH). Prior to the cycle
Figure1. Clinical spectrum of the Japa-
nese case. (a) Annular multiple circinate er-
ythema with migration over the thigh of
case 1 (age 1 y). (b) Multiple vesicles on the
dorsal side of the left hand of case 1 (age 1
y). (c) A skin biopsy discloses an extensive
split through the basal cell layer. (d) Normal
control demonstrates strong staining with
anti-K5 antibody (C50). (e) No reactivity to
anti-K5 antibody (C50) in the epidermis of
case 1 specimen. (f) Normal control demon-
strates strong staining with anti-K5 anti-
body (RCK102). (g) Faint reactivity to anti-
K5 antibody (RCK102) in the basal cells of
case 1 specimen. (h) Electron microscopy of
skin biopsy of case 1 discloses acantholysis
of spinous cells and no aggregation of tono-
¢laments.
Figure 2. Clinical spectrum of the Kor-
ean family. (a) Filled symbols in the pedigree
represent a¡ected individuals. An arrow indi-
cates the index patient. All of the a¡ected in-
dividuals indicated by asterisks were found to
contain the mutation. (b) Migratory circinate
erythema and vesicles on the area a¡ected by
erythema over the thigh of individual 1 (age 1
y). (c) Generalized hypopigmented and hyper-
pigmented patches on the trunk and extremi-
ties of individual 2; all a¡ected adult members
in the family had similar pigmentary changes
as her skin lesion. (d) A skin biopsy discloses
an extensive split through the basal cell layer.
(e) Normal control skin demonstrates strong
staining against anti-K5 antibody (C50). ( f )
No reactivity to anti-K5 antibody (C50) in
the epidermis of case 1 specimen.
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sequence reaction, the PCR products were puri¢ed for sequencing using
MicroSpin Columns (Amersham Pharmacia Biotech, Piscataway, NJ). In
order to exclude the possibility of DNA polymerase slippage during
PCR ampli¢cation, PCR was performed in triplicate for each sample.
Sequence analysis was performed on an automated sequencer (ALOKA,
Tokyo, Japan) using the primer-labeled method; the phage M13 (^21)
forward and reverse primers were used as the universal labeled primer.
The gene fragment carrying the 1649delG mutation was ampli¢ed with
the following primers: forward, 50 -TGTAAAACGACGGCCAGTAAGG-
GGGTCCAGTAGAGTGC-30, and reverse, 50 -CAGGAAACAGCTATGA-
CCATTTGACGCTGGAGCTGCTA-30; the underlined tails represent the
M13 forward and reverse sequences. Every reaction was repeated three
times. A total of 50 control individuals were tested by the same methods.
RESULTS
Histology Hematoxylin and eosin staining of specimens
obtained from small vesicles on the leg showed an extensive
split through the basal layer of the epidermis (Figs 1c, 2d).
Electron microscopy revealed a marked reduction in the
numbers of both desmosomes and keratin intermediate ¢laments
in the basal cells, and no evidence of tono¢lament clumping,
resulting in acantholysis of the spinous cells immediately above
the basal cell layer (Fig 1h).
Immunohistochemistry showed extremely faint K5 staining in
basal cells using the anti-K5 monoclonal antibody (RCK102), and
no staining with monoclonal antibody C-50 in case 1 (Fig 1e, g).
Conversely, normal control skin yielded positive staining with
both antibodies (Fig 1d, f ). In contrast, normal K14 staining in
basal cells was found in both the control and patient skin
samples (data not shown). These results suggest an underlying
defect in the K5 molecule. The same results were observed in the
Korean cases (Fig 2e, f ).
Mutation analysis This analysis revealed a single deletion
mutation (1649delG) in exon 9 of the KRT5 gene for all a¡ected
individuals. As other members in the Japanese family neither
were a¡ected by the same disorder nor had the same mutation,
this deletion mutation appears to have occurred as a de novo
event. Interestingly, the same mutation (1649delG) in exon 9 was
observed in each of the a¡ected Korean family members
examined, i.e., the proband, her mother, and her uncle (Fig 2a).
No other mutations were detected in the entire KRT5 and
KRT14 genes. The heterozygous deletion mutation (1649delG) in
the K5 V2 domain of these patients is predicted to produce a
mutant K5 with a frameshift of its terminal 41 amino acids,
resulting in a protein 35 amino acids longer than the wild-type
protein and caused by a delayed termination codon (Fig 3).
DISCUSSION
We examined two unrelated cases with EBS, i.e., an infant Japa-
nese female and a Korean family. In each case, the patient had a
phenotype that was less severe than EBS-DM but rather unusual,
showing peculiar migratory circinate erythema and multiple ve-
sicles on the area a¡ected by the erythema (Figs 1, 2). The lesions
healed with brown pigmentations but not scars. Mucous mem-
branes and nails were not a¡ected. Although the patients have
clinical ¢ndings resembling EBS-DM in terms of circular ar-
rangement of vesicles, their clinical features of markedly circinate
and prominent erythema with active migration were quite di¡er-
ent from this classical EBS subtype. Electron microscopy ¢nd-
ings also are distinct from those in EBS-DM, in which spherical
clumpings of keratin ¢laments are seen. The diagnostic criteria of
EBS-DM are the presence of herpetiform blisters and the ¢nding
of clumped tono¢laments on electron microscopy (Irvine and
McLean, 1999). As such, we propose the terminology ‘‘EBS with
migratory circinate erythema’’ to describe the present EBS sub-
type, as this accurately describes these ¢ndings. These unrelated
patients in Japan and Korea with a unique type of EBS have
a novel mutation in the keratin gene KRT5, i.e., a frameshift
and delayed stop codon inconsistent with any subtype described
previously.
Mutations in KRT5 or KRT14 that produce a termination co-
don positional change have been reported in several cases (Muller
et al, 1999; Gu et al, 2002).The mutation reported here is the farth-
est downstream, however, creating a delayed termination codon
not previously reported. It is interesting to note that an elongated
mutant of another corni¢ed envelope matrix protein interferes
with nuclear functions of di¡erentiating keratinocytes and causes
Vohwinkel syndrome (Ishida-Yamamoto et al, 2000). Thus, the
Figure 3. Mutation analysis of the
EBS patients. (a) In the a¡ected Japa-
nese girl, sequence analysis of PCR frag-
ments discloses a heterozygous deletion
mutation (1649delG) in exon 9 of
KRT5. This mutation leads to a frame-
shift and delayed termination codon. (b)
Comparison of amino acid sequence of
wild-type and mutant K5 spanning the
V2 domain. Numbers denote the amino
acid positions. The region a¡ected by the
mutation is indicated in the schematic
drawing of K5.
484 GU ETAL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
elongated mutant K5 reported here might either interfere with
the normal function of una¡ected K5 or have e¡ects on other
matrix protein interactions. This may explain the negative results
in immunohistochemistry for K5; i.e., the elongated tail region
may mask the normal K5 epitope produced by heterozygous nor-
mal gene.
AlthoughV2 mutation in K5 has never been reported, two dif-
ferent frameshift mutations were recently demonstrated in theV2
domain of K1 (Sprecher et al, 2001;Whittock et al, 2002). One was
a very severe form of ichthyosis hystrix CurthMacklin and the
other was mild striate palmoplantar keratoderma. Their pheno-
types were quite di¡erent due to the subtle di¡erence in the num-
ber of glycine loops and only six amino acid residues (Whittock
et al, 2002). These cases suggest that the faint defect in V2 of K1
might prohibit or interfere with the normal functional interac-
tion between keratin intermediate ¢laments and other proteins,
thus leading to the disease pathogenesis.
In the milder forms of EBS, the mutations occur outside the
highly conserved helix boundary motifs, and ¢laments appear
to be essentially normal on electron microscopy (McLean and
Lane, 1995). Electron microscopy of skin biopsies in our case
showed a reduction in the number of keratin intermediate ¢la-
ments in the basal cells but no tono¢lament clumpings (Fig 1h).
In addition, although K14 was detectable using immunohisto-
chemistry, K5 expression was either faint or undetectable. It is
possible that the frameshift mutation may interfere with normal
protein folding due to the aberrant extended tail region.This also
may explain why the present mutation, although occurring in a
non-hot-spot and nonhelix region V2 domain, may interfere
with the function of the protein. This elongated mutant keratin
protein, having an abnormal 41 amino acid sequence and being
35 amino acids longer than wild-type K5 protein, is likely to in-
terfere with functional interaction between keratin and associated
proteins, leading to an atypical clinical phenotype, which has
never been reported. This interpretation is quite feasible, as the
same novel mutation of KRT5 gene and the same unique clinical
phenotype of migratory circinate erythema and vesicles were
found in the two unrelated families in Japan and Korea. Addi-
tional detailed studies of the aberrant keratin protein in these
cases must be completed to understand the critical function for
the tail region of the keratin protein.
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